Hold at neutral weight with 0% new capital as unconfirmed 200 SMA pivot lacks medium-term confirmation; trim 25-30% on $70.02 stall
Hold at true benchmark weight neutralizes chop drag while respecting the 8/20 timing lesson against unconfirmed pivot entry. Bear case unresolved (200 SMA defending, dividend at 1.27x FCF coverage, no FDA action catalyst) prevents Underweight. Setup unconfirmed (1.5-2 of 5 triggers fired vs 2 of 5 required) prevents Overweight/Buy. Collect 6.27% yield as total-return offset during chop.
| Position | Action |
|---|---|
| Current position | Maintain true benchmark weight neutral; 0% new capital deployment at $68.65 |
| Price stalls at $70.02 for 2+ sessions | Trim 25-30% of position |
| Daily close below $64.79 on volume >10M | Hard stop exit |
| Price falls below $60.00 | Full exit |
MO is genuinely cheap at 11.7x forward earnings with a 6.27% covered dividend and asymmetric double-digit upside potential, offering income-focused investors a high-yield, low-volatility anchor in a "higher for longer" rate environment.
| Indicator | Value | Signal |
|---|---|---|
| close | 68.65 | neutral |
| open | 68.08 | neutral |
| high | 68.75 | neutral |
| low | 67.70 | neutral |
| volume | 5,842,231 | neutral |
| 10_ema | 67.59 | bullish |
| 50_sma | 70.02 | bearish |
| 200_sma | 64.79 | bullish |
| bollinger_upper | 70.09 | neutral |
| bollinger_mid | 66.84 | neutral |
| bollinger_lower | 63.59 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful retest of $64.79-$66.00 range with stabilization
Then: Add to position
Q2 weakness was a temporary distortion, not fundamental deterioration; underlying business is strengthening with management raising 2026 guidance
↩ rebuts: “The bear's reliance on the 'Q2 missed consensus' narrative”
EV: +11-20% (price appreciation to $76-82); +17-26% total return including 6.27% dividend · concedes: MO is up 95% over five years, raising expectations, but historical returns don't predict future valuations which remain cheap at 11.7x forward P/E; The PMI deal has no 2026 P&L impact and won't drive results until 2027+; Consumer staples lagging S&P 500 is a current reality, though sector rotation is mean-reverting; Tax-aware retail flow drag is a structural feature of the investor base; Technical picture shows ATR compression (2.24 to 1.64, a 27% drop) signaling unresolved direction
MO is a value trap: the dividend yield is attractive, but structural headwinds (declining volumes, regulatory risk, failed diversification, negative equity, and sector underperformance in an AI-led tape) make the stock fairly valued at 14.5x TTM, not cheap as the bull claims, with asymmetric downside risk.
· concedes: MO has a stable dividend and fortress balance sheet; The 6.27% yield is genuinely attractive for income-focused investors; MO holds up well in market drawdowns; Some yield-supportive rotation is theoretically possible if tech exhausts
→ vs conservative: Waiting for confirmed close above 70 means buying into the resistance zone where sellers are most likely to defend, eliminating risk-reward asymmetry entirely; waiting for 64 to 66 retest means chasing a setup that likely won't materialize since the 200 SMA at 64.79 is a hard floor with massive confluence support from the Bollinger lower band and higher-lows pattern argues against it
→ vs neutral: MO isn't priced for multiple expansion but for yield, durability, and modest re-rating; forward P/E of 11.71 against normalized forward EPS of 5.86 implies fair value of 76 to 82 based on 13 to 14 multiple which is maintenance not expansion; PEG ratio of 2.68 is a growth metric misapplied to a mature cash compounder that trades on yield and FCF coverage not PEG; dismissing raised floor on 2026 guidance as 'soft' ignores that management explicitly cited pricing power, margin expansion, and import-export benefits in a declining volume environment which is a bullish operating signal
| rsi | 51.91 | neutral |
| macd_line | -0.53 | bearish |
| macd_signal | -1.02 | bearish |
| macd_histogram | +0.49 | bullish |
| atr | 1.64 | neutral |
Support: 63.59 · 64.79 · 66.84 · 67.59 | Resistance: 70.02 · 70.09 · 73 · 75
MO exhibits a "bearish-above-bullish" regime: long-term uptrend intact (200 SMA rising at 64.79, price +5.9%), intermediate trend down (price 1.95% below declining 50 SMA at 70.02), short-term momentum turning positive (MACD histogram positive for 3 sessions, 10 EMA just reclaimed at 67.59). Volatility compressing (ATR fell from 2.24 peak to 1.64, ~27% reduction) signals coiled energy. Key resistance at 70.00–70.10 (50 SMA + Bollinger upper + breakdown supply zone); key support at 64.00–66.80 (200 SMA + Bollinger mid). HOLD rating: existing longs protected under 66.80; new entries deferred until confirmed close >70 (bullish breakout) or retest-and-hold of 64–66 (re-entry).
Market Cap
$114.63 B
P/E (TTM)
14.45x
Forward P/E
11.71x
EV/EBITDA
~8.3x
P/B
-42.96x
Dividend Yield
6.27%
EPS (TTM)
$4.75
Forward EPS
$5.86
Beta
0.495
Gross Margin (TTM)
87.2%
Operating Margin (TTM)
61.5%
Profit Margin (TTM)
39.0%
EBITDA (TTM)
$15.77 B
Net Income (TTM)
$7.95 B
ROA
29.5%
Total Assets
$35.02 B
Total Debt
$25.71 B
Net Debt
$21.24 B
Net Debt / EBITDA
1.35x
Stockholders' Equity
($3.50 B)
Treasury Stock
$43.18 B
Goodwill & Intangibles
$17.66 B
Current Ratio
0.52
Operating Cash Flow (2025)
$9.29 B
CapEx (2025)
$0.22 B
Free Cash Flow (2025)
$9.07 B
Dividends Paid (2025)
$6.96 B
Buybacks (2025)
$1.00 B
52-Week High
$77.06
52-Week Low
$54.70
50-Day Avg
$70.03
200-Day Avg
$66.05
Net Revenue (2025)
$20.14 B
Net Revenue (2021)
$20.69 B
Gross Profit (2025)
$14.54 B
Operating Income (2025)
$9.90 B
Net Income (2025)
$6.95 B
Normalized EBITDA (2025)
$12.97 B
2025 Impairment Charge
$1.158 B
2025 Write-off/Restructuring
$978 M
Price Target Low
$76
Price Target High
$82
Strengths
Concerns
Altria Group (MO) is a textbook defensive income equity with fortress-like pricing power, generating $9.07B in annual free cash flow that supports a 6.27% dividend yield. The 2025 earnings decline reflects non-cash impairments ($2.14B in unusual charges) rather than underlying business deterioration, as normalized EBITDA of $12.97B held stable. Trading at 11.71x forward P/E and 8.3x EV/EBITDA with a 6.27% yield, MO offers a compelling valuation discount to consumer staples peers for income-focused and defensive equity investors.
Macro: The dominant macro signal for MO is a firmly reinforcing "higher for longer" rates regime: prediction markets show 89% probability of no Fed rate cuts in 2026 (up 3.3 percentage points WoW), with zero probability assigned to ≥10 or ≥12 cuts. This is explicitly characterized as a tailwind for high-yield dividend equities, as MO's ~6%+ dividend remains well above 10-year Treasury yields that Barron's coverage notes have "topped 4.7%." The income-yield advantage vs. cash/T-bills stays wide, and discount-rate pressure on equity valuations is lower than a cut-implied scenario would suggest. However, the broader consumer staples sector is underperforming the S&P 500 by a wide margin (-4.8% vs +10.5% over 6 months), creating a sector-relative headwind for MO even if its absolute total return remains constructive. Global news flow is dominated by commodities/mining with limited direct spillover to tobacco.